TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway
Top Cited Papers
- 12 October 2003
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 4 (11) , 1144-1150
- https://doi.org/10.1038/ni986
Abstract
Recognition of pathogens by Toll-like receptors (TLRs) triggers innate immune responses through signaling pathways mediated by Toll–interleukin 1 receptor (TIR) domain–containing adaptors such as MyD88, TIRAP and TRIF. MyD88 is a common adaptor that is essential for proinflammatory cytokine production, whereas TRIF mediates the MyD88-independent pathway from TLR3 and TLR4. Here we have identified a fourth TIR domain–containing adaptor, TRIF-related adaptor molecule (TRAM), and analyzed its physiological function by gene targeting. TRAM-deficient mice showed defects in cytokine production in response to the TLR4 ligand, but not to other TLR ligands. TLR4- but not TLR3-mediated MyD88-independent interferon-β production and activation of signaling cascades were abolished in TRAM-deficient cells. Thus, TRAM provides specificity for the MyD88-independent component of TLR4 signaling.Keywords
This publication has 46 references indexed in Scilit:
- Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling PathwayScience, 2003
- Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shockBiochemical and Biophysical Research Communications, 2003
- The Toll–IL-1 receptor adaptor family grows to five membersTrends in Immunology, 2003
- Toll-Like ReceptorsAnnual Review of Immunology, 2003
- TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β inductionNature Immunology, 2003
- A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathwaysInternational Immunology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophagesNature Immunology, 2002
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODNCellular Immunology, 2000